Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

A village beyond Sardinia's blue zone shows striking survival among older women

27

Oct 2026

A village beyond Sardinia's blue zone shows striking survival among older women

Researchers studying Bolotana, Sardinia, found that women had exceptionally high estimated late-life survival during 2021–2025, with their probability of surviving from age 70 to 100 exceeding regional and national averages by more than threefold. Earlier demographic estimates showed a much smaller survival advantage, prompting the authors to classify Bolotana as a candidate longevity blue zone that requires further investigation.

Amyloid fibers help sperm deliver RNA to mouse embryos

27

Oct 2026

Amyloid fibers help sperm deliver RNA to mouse embryos

Researchers identified RNA-associated amyloid fibrils in human seminal fluid and demonstrated that synthetic PAP fibrils could enter mammalian sperm. In mouse IVF experiments, these fibrils helped sperm deliver RNA to embryos, where the detected reporter-protein signal was at least tenfold higher than without fibril exposure.

UC San Diego receives major grant to secure healthcare cybersecurity

27

Oct 2026

UC San Diego receives major grant to secure healthcare cybersecurity

The University of California San Diego Center for Healthcare Cybersecurity has received an award from the Advanced Research Projects Agency for Health (ARPA-H) to lead the Preventative Assessment and Network Analysis of Cyber Essential Abilities for Health (PANACEA-H) project in collaboration with the American Hospital Association (AHA), the University of Maryland and the University of Minnesota.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.